The Cold Agglutinin Disease treatment market is expanding due to rising awareness, clinical development in complement-targeted agents, and unmet need for therapies for rare autoimmune hemolytic anemia. https://www.datamintelligence.com/research-report/cold-agglutinin-disease-treatment-market